Zisman A - Search Results

1

A model to explore the interaction between muscle insulin resistance and beta-cell dysfunction in the development of type 2 diabetes.

Mauvais-Jarvis F, Virkamaki A, Michael MD, Winnay JN, Zisman A, Kulkarni RN, Kahn CR. Mauvais-Jarvis F, et al. Among authors: zisman a. Diabetes. 2000 Dec;49(12):2126-34. doi: 10.2337/diabetes.49.12.2126. Diabetes. 2000. PMID: 11118016

2

Lessons for human diabetes from experimental mouse models.

Kulkarni RN, Zisman A. Kulkarni RN, et al. Among authors: zisman a. Curr Diab Rep. 2003 Apr;3(2):168-75. doi: 10.1007/s11892-003-0041-x. Curr Diab Rep. 2003. PMID: 12728643 Review.

3

Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance.

Zisman A, Peroni OD, Abel ED, Michael MD, Mauvais-Jarvis F, Lowell BB, Wojtaszewski JF, Hirshman MF, Virkamaki A, Goodyear LJ, Kahn CR, Kahn BB. Zisman A, et al. Nat Med. 2000 Aug;6(8):924-8. doi: 10.1038/78693. Nat Med. 2000. PMID: 10932232

4

Muscle-specific deletion of the Glut4 glucose transporter alters multiple regulatory steps in glycogen metabolism.

Kim YB, Peroni OD, Aschenbach WG, Minokoshi Y, Kotani K, Zisman A, Kahn CR, Goodyear LJ, Kahn BB. Kim YB, et al. Among authors: zisman a. Mol Cell Biol. 2005 Nov;25(21):9713-23. doi: 10.1128/MCB.25.21.9713-9723.2005. Mol Cell Biol. 2005. PMID: 16227617 Free PMC article.

5

Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.

Kim JK, Zisman A, Fillmore JJ, Peroni OD, Kotani K, Perret P, Zong H, Dong J, Kahn CR, Kahn BB, Shulman GI. Kim JK, et al. Among authors: zisman a. J Clin Invest. 2001 Jul;108(1):153-60. doi: 10.1172/JCI10294. J Clin Invest. 2001. PMID: 11435467 Free PMC article.

6

Development of albuminuria and glomerular lesions in normoglycemic B6 recipients of db/db mice bone marrow: the role of mesangial cell progenitors.

Zheng F, Cornacchia F, Schulman I, Banerjee A, Cheng QL, Potier M, Plati AR, Berho M, Elliot SJ, Li J, Fornoni A, Zang YJ, Zisman A, Striker LJ, Striker GE. Zheng F, et al. Among authors: zisman a. Diabetes. 2004 Sep;53(9):2420-7. doi: 10.2337/diabetes.53.9.2420. Diabetes. 2004. PMID: 15331554

7

Randomized study of basal-bolus insulin therapy in the inpatient management of patients with type 2 diabetes (RABBIT 2 trial).

Umpierrez GE, Smiley D, Zisman A, Prieto LM, Palacio A, Ceron M, Puig A, Mejia R. Umpierrez GE, et al. Among authors: zisman a. Diabetes Care. 2007 Sep;30(9):2181-6. doi: 10.2337/dc07-0295. Epub 2007 May 18. Diabetes Care. 2007. PMID: 17513708 Clinical Trial.

8

BeAM value: an indicator of the need to initiate and intensify prandial therapy in patients with type 2 diabetes mellitus receiving basal insulin.

Zisman A, Morales F, Stewart J, Stuhr A, Vlajnic A, Zhou R. Zisman A, et al. BMJ Open Diabetes Res Care. 2016 Apr 13;4(1):e000171. doi: 10.1136/bmjdrc-2015-000171. eCollection 2016. BMJ Open Diabetes Res Care. 2016. PMID: 27110368 Free PMC article.

9

Correction to: Bedtime-to-Morning Glucose Difference and iGlarLixi in Type 2 Diabetes: Post Hoc Analysis of LixiLan-L.

Zisman A, Dex T, Roberts M, Saremi A, Chao J, Aroda VR. Zisman A, et al. Diabetes Ther. 2019 Feb;10(1):327. doi: 10.1007/s13300-018-0544-8. Diabetes Ther. 2019. PMID: 30515716 Free PMC article.

10

Resistance to glomerulosclerosis in B6 mice disappears after menopause.

Zheng F, Plati AR, Potier M, Schulman Y, Berho M, Banerjee A, Leclercq B, Zisman A, Striker LJ, Striker GE. Zheng F, et al. Among authors: zisman a. Am J Pathol. 2003 Apr;162(4):1339-48. doi: 10.1016/S0002-9440(10)63929-6. Am J Pathol. 2003. PMID: 12651625 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

237 results

Search Page

Filters